Edition:
United Kingdom

Livzon Pharmaceutical Group Inc (1513.HK)

1513.HK on Hong Kong Stock

23.40HKD
23 Oct 2018
Change (% chg)

HK$-0.60 (-2.50%)
Prev Close
HK$24.00
Open
HK$24.50
Day's High
HK$24.50
Day's Low
HK$23.25
Volume
663,612
Avg. Vol
822,681
52-wk High
HK$55.08
52-wk Low
HK$22.05

Latest Key Developments (Source: Significant Developments)

Livzon Pharmaceutical Group to sell 15 pct stake in pharmaceuticals firm for 66.2 mln yuan
Tuesday, 24 Apr 2018 

April 24(Reuters) - Livzon Pharmaceutical Group Inc <000513.SZ>:Says it plans to sell 15 percent stake in a Guangdong-based pharmaceuticals company for 66.2 million yuan .Says it will hold 77.1 percent stake in the pharmaceuticals company after the transaction .  Full Article

Livzon Pharmaceutical's Q1 Net Profit Up 26.3 Pct Y/Y
Monday, 23 Apr 2018 

April 23 (Reuters) - Livzon Pharmaceutical Group Inc <000513.SZ>1513.HK::SAYS Q1 NET PROFIT UP 26.3 PERCENT Y/Y AT 347.4 MILLION YUAN ($55.08 million).  Full Article

Livzon Pharmaceutical Group unit receives approval for drug clinical trial
Tuesday, 2 Jan 2018 

Jan 2 (Reuters) - Livzon Pharmaceutical Group Inc <000513.SZ>:Says Zhuhai-based biotechnology unit received drug clinical trial approval for drug named Recombinant Human anti-RANKL Monoclonal Antibody Solution for Injection.  Full Article

Livzon Pharmaceutical Co Announces Change In Shareholding Structure Of Livzon MABPharm
Thursday, 21 Dec 2017 

Dec 21 (Reuters) - Livzon Pharmaceutical Group Inc <000513.SZ>::CO & JOINCARE PHARMACEUTICAL INDUSTRY ENTERED FRAMEWORK AGREEMENT RELATING TO CAPITAL CONTRIBUTION TO LIVZON BIOLOGICS.‍ACQUISITION CONSIDERATION OF 100% OF EQUITY INTERESTS OF LIVZON MAB BY BIOLOGICS TO BE RMB600 MILLION​.  Full Article

Livzon Pharmaceutical Group unit receives approval for drug clinical trial
Friday, 3 Nov 2017 

Nov 3 (Reuters) - Livzon Pharmaceutical Group Inc <000513.SZ>:Says its unit received drug clinical trial approval for Recombinant Humanized anti-PD-1 Monoclonal Antibody for Injection .  Full Article

Livzon Pharmaceutical's net profits up in Q3, Jan-Sept
Wednesday, 25 Oct 2017 

Oct 25 (Reuters) - Livzon Pharmaceutical Group Inc <000513.SZ>1513.HK:Says Q3 net profit up 1,719.2 percent y/y at 3.7 billion yuan ($556.85 million), 9-month net profit up 590.7 percent y/y at 4.2 billion yuan.  Full Article

Livzon Pharmaceutical sees FY net profit attributable between RMB4.32 bln - RMB4.48 bln
Wednesday, 25 Oct 2017 

Oct 25 (Reuters) - Livzon Pharmaceutical Group Inc <000513.SZ>::Sees FY net profit attributable between RMB4.32 billion - RMB4.48 billion.  Full Article

Livzon Pharmaceutical Group units receive approval for drug clinical trials
Monday, 18 Sep 2017 

Sept 18 (Reuters) - Livzon Pharmaceutical Group Inc <000513.SZ>:* Says its units received drug clinical trials approval for drug, Triptorelin Acetate Microspheres for Injection.  Full Article

Livzon Pharma sees net profit up 20-30 pct in 2016
Friday, 13 Jan 2017 

Livzon Pharmaceutical Group Inc <000513.SZ><1513.HK> :Says it expects net profit to rise 20-30 percent y/y in 2016 at 747.2-809.4 million yuan ($117.36 million).  Full Article